Universitätsklinikum Heidelberg

ChatGPT’s performance in German OB/GYN exams – paving the way for AI-enhanced medical education and clinical practice (2023) Riedel M, Kaefinger K, Stuehrenberg A, Ritter V, Amann N, Graf A, Recker F, et al. Journal article Update Breast Cancer 2023 Part 2 - Advanced-Stage Breast Cancer. (2023) Lux MP, Hartkopf AD, Fehm TN, Welslau M, Müller V, Schütz F, Fasching P, et al. Journal article Regional Variation in Hemoglobin Distribution Among Individuals With CKD: the ISN International Network of CKD Cohorts. (2023) Canney M, Induruwage D, Tang M, Alencar de Pinho N, Er L, Zhao Y, Djurdjev O, et al. Journal article Digital emergency management in acute and emergency care networks. Delineation of key points by the ZTM expert council Digitales Notfallmanagement im Netzwerk der Akut- und Notfallversorgung. Eckpunktepapier des Expertenrats des ZTM (2023) Eder PA, Soda H, Kumle B, Dodt C, Dormann H, Popp E, Flasch B, et al. Journal article Guidelines for mouse and human DC functional assays (2022) Clausen BE, Amon L, Backer RA, Berod L, Bopp T, Brand A, Burgdorf S, et al. Journal article Diagnosis and treatment of adult-onset Still's disease: a concise summary of the German society of rheumatology S2 guideline (2022) Vordenbaeumen S, Feist E, Rech J, Fleck M, Blank N, Haas JP, Koetter I, et al. Journal article Immune checkpoint inhibition and targeted therapy for melanoma: A patient-oriented cross-sectional comparative multicentre study (2022) Thiem A, Mashhadiakbar P, Cussigh C, Hassel JC, Grimmelmann I, Gutzmer R, Schlaak M, et al. Journal article Expanding the molecular spectrum of gene fusions in endometrial stromal sarcoma: Novel subunits of the chromatin remodeling complexes PRC2 and NuA4/TIP60 as alternative fusion partners (2022) Dermawan JKK, Dashti N, Chiang S, Turashvili G, Dickson BCC, Ellenson LHH, Kirchner M, et al. Journal article CAD-RADS Scoring using Deep Learning and Task-Specific Centerline Labeling (2022) Denzinger F, Wels M, Taubmann O, Gülsün MA, Schöbinger M, Andre F, Buss SJ, et al. Conference contribution, Conference Contribution Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy—the MecMeth/NOA-24 trial (2022) Zeyen T, Potthoff AL, Nemeth R, Heiland DH, Burger MC, Steinbach JP, Hau P, et al. Journal article